85
Participants
Start Date
February 27, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2028
roginolisib
rognolisib
Investigator choice of standard therapy
Investigator will choose the most appropriate treatment standardly given to patients
NOT_YET_RECRUITING
Complejo Hospitalario Universitario de Santiago - CHUS, Santiago de Compostela
NOT_YET_RECRUITING
IRCCS Istituto Clinico Humanitas, Rozzano
NOT_YET_RECRUITING
Hospital Universitario La Paz, Madrid
NOT_YET_RECRUITING
IRCSS Istituto Oncologico Veneto UOS Oncologia 2 del Melanoma Ospedale Busonera, Padua
NOT_YET_RECRUITING
Consorcio Hospital General Universitario de València - CHGUV, Valencia
RECRUITING
A.O.U.S. Santa Maria delle Scotte, Siena
RECRUITING
SSD Tumori Rari e Melanoma Viale Orazio Flacco, Bari
NOT_YET_RECRUITING
"IRCSS National Cancer Institute, G.Pascale Foundation Dip. CORP-S di Ricerca ed Assistenziale Cute, Melanoma lmmunologia Oncologica Sperimentale e Terapie Innovative", Napoli
RECRUITING
Institut Catala d'Oncologia - ICO L'Hospitalet, Barcelona
RECRUITING
Hospital Universitario Virgen Macarena, University of Seville, Seville
RECRUITING
East and North Hertfordshire NHS Trust (Mount Vernon Cancer Centre), Northwood
NOT_YET_RECRUITING
The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington
RECRUITING
Beatson West of Scotland Cancer Centre, Glasgow (NHS Greater Glasgow & Clyde), Glasgow
RECRUITING
University College London Hospital NHS, London
RECRUITING
Royal Marsden Hospital, London
RECRUITING
University Hospital Southampton NHS Foundation, Southampton
Lead Sponsor
iOnctura
INDUSTRY